pharmaphorum

MARCH 18, 2022

Gaming industry veteran Jon David, responsible for highly-downloaded mobile games, including the Bejeweled and Plants vs Zombies franchises, has moved into the digital health arena by taking a senior position at Akili Interactive Labs. As Akili’s chief product officer, his role will be to make sure that the company’s game-based therapies are as engaging as “high-end entertainment,” ensuring that they are fun to play, as well as therapeutically effective.

FDA 91

FDA 91

Pharmig

MARCH 18, 2022

Everyone wants to know where they come from, and microbiologists are no different. But were we grown in a petri dish. The post Routes into microbiology – how apprenticeships help appeared first on Pharmig.

52

52

pharmaphorum

MARCH 18, 2022

AstraZeneca (AZ), GlaxoSmithKline (GSK), Sanofi, Allergan and Britannia Pharma have been reprimanded for running advertisements that breached the Association of British Pharmaceutical Industry (APBI) code of practice. Complaints upheld by the Prescription Medicines Code of Practice Authority (PMCPA) include two against AZ and Allergan – now part of AbbVie – related to promotion of medicines on social media sites, including LinkedIn.

Vaccines 64

Vaccines 64

Pharma Mirror

MARCH 18, 2022

HONG KONG, Sisram Medical Ltd (the “Company” or “Sisram”, stock code: 1696.HK; together with its subsidiaries referred as the “Group”), a global consumer wellness group, featuring a never-before-seen synergistic ecosystem of business building blocks and consumer-focused branding, ranging from medical aesthetics capital equipment, via injectables therapy, aesthetic dentistry, personal care and more, today announced its audited consolidated annual results for th

52

52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

MARCH 18, 2022

Merck & Co’s Keytruda is poised to move even earlier in the treatment of patients with non-small cell lung cancer (NSCLC) after showing efficacy when used to prevent the cancer returning after surgery to remove it in a phase 3 trial. The results of the KEYNOTE-091 trial showed that Keytruda (pembrolizumab) reduced death or disease recurrence by 24% compared to placebo when used as adjuvant therapy after surgery in an all-comer NSCLC population regardless of PD-L1 expression.

Chemotherapy 59

Chemotherapy Labelling FDA 59

Pharma Times

MARCH 18, 2022

With the significant increase in entries this year, the competition to name the finalists proved incredibly tough. The International Clinical Researcher judging panel, however, have made their decisions and the finalists have now been announced.

43

43

Pharma Times

MARCH 18, 2022

The hybrid of Delta and Omicron, known as ‘Deltacron’, has been identified in France, Denmark and the Netherlands

50

50

Pharma Times

MARCH 18, 2022

Approval is significant as waning restrictions present significant threats to many immunocompromised people across the UK

38

38